A stepped-wedge cluster randomised controlled trial of a primary health care mobile health system for cardiovascular risk management in rural Andrha Pradesh

Conditions

Health Condition 1: I219- Acute myocardial infarction, unspecified Health Condition 2: null- CVD Health Condition 3: I20-I25- Ischemic heart diseases

Devarsetty Praveen, David Peiris, Stephen MacMahon, Kishor Mogulluru, Arvind Raghu et al. (15 authors)

BMC Public Health2018-11-1522 citations

10.1186/s12889-018-6142-x

SMARTHealth India: Development and Field Evaluation of a Mobile Clinical Decision Support System for Cardiovascular Diseases in Rural India

Devarsetty Praveen, Anushka Patel, Arvind Raghu, Gari D. Clifford, Pallab K Maulik et al. (10 authors)

JMIR mhealth and uhealth2014-12-08136 citations

10.2196/mhealth.3568

A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial.

Praveen D, Patel A, McMahon S, Prabhakaran D, Clifford GD, Maulik PK, Joshi R, Jan S, Heritier S, Peiris D.

2013-11-2538 citations

10.1186/1748-5908-8-137

Interventions

Intervention1: CDSS, Training: The health workers will screen individuals for risk of CVD using the CDSS and will refer the patients to the doctors for confirmation and medication. The health workers

Eligibility

Inclusion criteria

Inclusion criteria: a. Resident of the village selected for the study b. should be able to provide informed consent

Exclusion criteria

Exclusion criteria: a. Individuals below 40 years b. People with intellectual disability that prevents them from comprehending the study principles and requirements

Design outcomes

Primary

Measure	Time frame
Difference in proportion of high risk individuals (with or without CVD) who are achieving optimal BP levels (Systolic BP greater than 140 mmHg) between the intervention and control periodsTimepoint: end of 2 years	—

Secondary

Measure	Time frame
-mean reduction in BP levels -receipt of lifestyle advice by a health care provider -change in other CVD risk factors -self-reported use of BP and other cardiovascular medicines -Quality of life (using the EQ-5D) -CVD eventsTimepoint: end of 2 years	—

Countries

India

Contacts

Public ContactDevarsetty Praveen

George Institute for Global Health

apatel@georgeinstitute.org04023558091

Outcome results

None listed